Jim Aggen, Ph.D.

VP, Medicinal Chemistry

Dr. Aggen has over 20 years of experience in medicinal chemistry. He most recently served as the Senior Director of Medicinal Chemistry at Revolution Medicines and earlier in his career held various positions at Oligiasis, Achaogen, Chemocentryx, Gilead Sciences and Theravance, as well as Associate Professor of Medicinal and Natural Products Chemistry at Northeastern University. Dr. Aggen has successfully led teams engaged in targeted drug discovery against multiple oncology targets including mTORC1 and KRAS, and has experience in the medicinal chemistry of larger molecules, including as an inventor of the aminoglycoside antibiotic plazomicin, now marketed as Zemdri. He also served in the US Marine Corps Reserves. Dr. Aggen was awarded a doctorate in synthetic organic chemistry from the University of California, Irvine, where he studied under Prof. Richard Chamberlin.VP, Medicinal Chemistry.

Go to Top